Trial intelligence / Profile preview

PENG block versus transmuscular quadratus lumborum block for postoperative analgesia after paediatric DDH surgery

PACTR202204798992849Phase 4Not yet recruiting

Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of bupivacaine in postoperative pain (2 arms). Primary endpoint: Time to first rescue analgesic requirement postoperatively. Planned start Apr 2022; status: not yet recruiting.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202204798992849.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202204798992849.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call